Pharmafile Logo
Pharmafocus logo
Advanced Search

obesity

Showing 15 posts of 61 posts found.

energy-bar-snack-chocolate-bar-chocolate-candy-1636220

‘Hugely disturbing’ rise in UK children with type 2 diabetes, report finds

August 14, 2017
Medical Communications, Sales and Marketing childhood obesity, diabetes, healthcare, life sciences, obesity, pharma, pharmaceuticals

A report from the Royal College of Paediatrics and Child Health (RCPCH) has highlighted a “hugely disturbing” rise in cases …

News

FDA investigating intragastric obesity treatment linked to five deaths

August 14, 2017
Medical Communications, Sales and Marketing life sciences, medicine, obesity, pharma, pharmaceutical

The FDA has launched an investigation after five deaths thought to be caused by an obesity treatment surgery in which …

News
shutterstock_87495637

Drug combinations can boost weight loss, research finds

July 19, 2017
Research and Development biotech, drugs, healthcare, obesity, pharma, pharmaceuticals, weight loss

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

News
MRI obese overweight

Novo Nordisk forms academic partnership with Washington Uni

November 4, 2015
Research and Development Novo Nordisk, diabetes, obesity

Novo Nordisk has launched a new research collaboration with researchers at the University of Washington, to develop new drugs for …

News
obesity

Innovative pipeline can transform obesity treatment, says GBI Research

October 8, 2015
Research and Development obesity

While the current obesity treatment market has a high level of unmet need, the therapeutic landscape could be transformed by …

News
body scan

Pfizer in metabolic disease push

September 11, 2015
Medical Communications, Research and Development AMRA, Pfizer, UK Biobank, med tech, metabolic disease, obesity

Pfizer has signed a research collaboration with a global medical health technology company, to investigate risk factors for metabolic conditions.  …

News
contrave

Takeda hits major snags with Contrave and Alisertib

May 14, 2015
Sales and Marketing Contrave, Takeda, alisertib, obesity, orexigen

Takeda is threatening to end its partnership with Orexigen to market the obesity drug Contrave, as allegations around its heart …

News
Novo image

Novo Nordisk obesity drug is launched in the US

April 23, 2015
Sales and Marketing Novo Nordisk, liraglutide, obesity, overweight, saxenda, world health organization

Novo Nordisk is rolling out its obesity drug Saxenda across the US for the treatment of obese adult patients. Saxanda …

News
Saxenda image

Novo Nordisk obesity drug gets EU approval

March 24, 2015
Sales and Marketing EMA, EU, FDA, Victoza, liraglutide, obesity, saxenda

Novo Nordisk’s obesity drug Saxenda has been approved by the European Commission for use across the EU. This approval follows …

News
Saxenda image

Novo Nordisk obesity drug shows added benefits

March 9, 2015
Sales and Marketing (liraglutide), Contrave, Novo Nordisk, Victoza, Xenical, liraglutide, obesity, saxenda, weight

New research by Novo Nordisk has suggested that its obesity drug Saxenda can help improve several other weight-related problems as …

News
Merck image

Merck invests $450m in NGM Biopharma

February 23, 2015
Sales and Marketing Merck, NGM Biopharma, NP201, diabetes, nonalcoholic steatohepatitis, obesity

Merck is to collaborate on drug development with biotech firm NGM Pharmaceuticals in a $450 million deal. The collaboration will …

News
Shire image

Shire drug approved for binge eating disorder

February 2, 2015
Sales and Marketing ADHD, FDA, Shire, Vyvanse, binge, eating, lisdexamfetamine dimesylate, obesity

Shire has become the first company to gain FDA approval for a treatment for binge eating disorder (BED) in adults …

News
VBLOC image

FDA approves novel obesity device

January 16, 2015
Medical Communications, Sales and Marketing EnteroMedics, FDA, Novo, VBLOC, diabetes, obesity, type 2

The US Food and Drug Administration has shown the green light to US firm EnteroMedics’ new obesity device VBLOC that …

News
Victoza image

FDA panel backs liraglutide for obesity

September 12, 2014
Manufacturing and Production, Sales and Marketing Arena Pharmaceuticals, Belviq, Novo Nordisk, Qsymia, Victoza, Vivus, diabetes, obesity

An FDA panel has voted 14-1 to allow a form of Novo Nordisk’s type 2 diabetes treatment Victoza to help …

News
fda image

Fourth diet pill makes it to US market

September 11, 2014
Manufacturing and Production, Sales and Marketing Contrave, FDA, Orexigen Therapeutics, diet, obesity

Orexigen Therapeutics has gained FDA approval for its new obesity treatment Contrave to help overweight patients reduce their food intake. …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026